MCID: LYM098
MIFTS: 30

Lymphomatous Meningitis

Categories: Cancer diseases, Immune diseases, Rare diseases

Aliases & Classifications for Lymphomatous Meningitis

MalaCards integrated aliases for Lymphomatous Meningitis:

Name: Lymphomatous Meningitis 59
Metastatic Malignant Neoplasm to the Leptomeninges 73
Meningeal Carcinomatosis 73
Meningeal Lymphoma 73

Classifications:



External Ids:

Orphanet 59 ORPHA329998
UMLS via Orphanet 74 C1704231
ICD10 via Orphanet 34 G03.8

Summaries for Lymphomatous Meningitis

MalaCards based summary : Lymphomatous Meningitis, also known as metastatic malignant neoplasm to the leptomeninges, is related to meningitis and lymphoma. An important gene associated with Lymphomatous Meningitis is TYMP (Thymidine Phosphorylase), and among its related pathways/superpathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Inflammatory Response Pathway. The drugs leucovorin and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include lymph node, brain and lung.

Wikipedia : 76 Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The... more...

Related Diseases for Lymphomatous Meningitis

Diseases related to Lymphomatous Meningitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 15)
# Related Disease Score Top Affiliating Genes
1 meningitis 10.7
2 lymphoma 10.4
3 lymphoma, hodgkin, classic 10.1
4 lymphoma, non-hodgkin, familial 10.1
5 central nervous system lymphoma 10.1
6 primary central nervous system lymphoma 10.1
7 intraocular lymphoma 9.9
8 peripheral t-cell lymphoma 9.9
9 eosinophilic meningitis 9.9
10 optic nerve disease 9.9
11 lipomatosis 9.9
12 neuropathy 9.9
13 cluster headache 9.9
14 headache 9.9
15 rectal neoplasm 9.7 CEACAM5 TYMP

Graphical network of the top 20 diseases related to Lymphomatous Meningitis:



Diseases related to Lymphomatous Meningitis

Symptoms & Phenotypes for Lymphomatous Meningitis

Drugs & Therapeutics for Lymphomatous Meningitis

Drugs for Lymphomatous Meningitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 123)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 58-05-9 6006 143
2
Methotrexate Approved Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable 59-05-2, 1959-05-2 126941
3
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
4
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 59-30-3 6037
5 Vitamin B9 Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
6 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
7 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
8 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
9 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
10 Dermatologic Agents Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
11 Antirheumatic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
12 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
13 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
14 Immunologic Factors Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
15 Folate Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
16 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
17 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18
Etoposide Approved Phase 2, Phase 3 33419-42-0 36462
19
Thiotepa Approved, Investigational Phase 2, Phase 3 52-24-4 5453
20
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Phase 1 6055-19-2, 50-18-0 2907
21
Carboplatin Approved Phase 2, Phase 3 41575-94-4 10339178 38904 498142
22
Dacarbazine Approved, Investigational Phase 2, Phase 3,Phase 3,Phase 1 4342-03-4 5351166
23
Temozolomide Approved, Investigational Phase 2, Phase 3,Phase 3,Phase 1 85622-93-1 5394
24
Iodine Approved, Investigational Phase 2, Phase 3,Phase 1 7553-56-2 807
25
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
26
Capecitabine Approved, Investigational Phase 3,Phase 2 154361-50-9 60953
27 Trofosfamide Investigational Phase 2, Phase 3 22089-22-1
28 Topoisomerase Inhibitors Phase 2, Phase 3,Phase 1
29 Etoposide phosphate Phase 2, Phase 3
30 Antineoplastic Agents, Alkylating Phase 2, Phase 3,Phase 3,Phase 1
31 Alkylating Agents Phase 2, Phase 3,Phase 3,Phase 1
32 Antineoplastic Agents, Phytogenic Phase 2, Phase 3,Phase 3
33 Antibodies, Monoclonal Phase 2, Phase 3,Phase 1
34 cadexomer iodine Phase 2, Phase 3,Phase 1
35 Antibodies Phase 2, Phase 3,Phase 1
36 Immunoglobulins Phase 2, Phase 3,Phase 1
37 Antimitotic Agents Phase 3,Phase 2
38 Protein Kinase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
39 Albumin-Bound Paclitaxel Phase 3
40
Erlotinib Hydrochloride Phase 3,Phase 2 183319-69-9 176871
41
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
42
rituximab Approved Phase 2,Phase 1 174722-31-7 10201696
43
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 1, Phase 2,Phase 2,Early Phase 1 1177-87-3
44
Dexamethasone Approved, Investigational, Vet_approved Phase 1, Phase 2,Phase 2,Early Phase 1 50-02-2 5743
45
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
46
Bevacizumab Approved, Investigational Phase 2,Phase 1 216974-75-3
47
Topotecan Approved, Investigational Phase 2,Phase 1 123948-87-8, 119413-54-6 60700
48
Pemetrexed Approved, Investigational Phase 1, Phase 2,Phase 2,Early Phase 1 150399-23-8, 137281-23-3 446556 60843
49
Trastuzumab Approved, Investigational Phase 1, Phase 2,Phase 2 180288-69-1 9903
50
Nivolumab Approved Phase 2 946414-94-4

Interventional clinical trials:

(show top 50) (show all 81)
# Name Status NCT ID Phase Drugs
1 Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis Unknown status NCT02590510 Phase 4 methotrexate
2 DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor Completed NCT00029523 Phase 4 Intrathecal (injected into the spinal fluid) DepoCyt;Intrathecal methotrexate;Intrathecal cytarabine (also known as ara-C)
3 Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children Completed NCT00749723 Phase 2, Phase 3 carboplatin;etoposide;temozolomide;thiotepa, carboplatin, etoposide;temozolomide, thiotepa;intraventricular etoposide;trofosfamide, etoposide
4 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases Recruiting NCT03275402 Phase 2, Phase 3
5 Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer Active, not recruiting NCT01645839 Phase 3 Liposomal Cytarabine
6 ANG1005 in Leptomeningeal Disease From Breast Cancer Not yet recruiting NCT03613181 Phase 3 ANG1005;Physician's Best Choice
7 Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Terminated NCT00096265 Phase 3 Erlotinib Hydrochloride;Temozolomide
8 Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases Unknown status NCT01818713 Phase 2 2B3-101
9 High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement Unknown status NCT00801216 Phase 2 High-dose sequential chemotherapy and autologous transplant
10 Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis Completed NCT01281696 Phase 2 Bevacizumab, etoposide, cisplatin;Intrathecal methotrexate
11 Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases Completed NCT02616393 Phase 2 Tesevatinib
12 A Pilot Study of Bevacizumab for Neoplastic Meningitis Completed NCT00924820 Phase 1, Phase 2 Bevacizumab
13 Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Completed NCT00992602 Phase 2 methotrexate;liposomal cytarabine
14 Monoclonal Antibody Therapy in Treating Patients With Brain Metastases Completed NCT00002751 Phase 1, Phase 2
15 Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases Completed NCT02654106 Phase 2 Temozolomide
16 Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment Completed NCT00005811 Phase 2 topotecan hydrochloride
17 Epothilone B in Treating Patients With CNS Metastases From Breast Cancer Completed NCT00450866 Phase 2
18 Ipilimumab and Nivolumab in Leptomeningeal Metastases Recruiting NCT02939300 Phase 2 Nivolumab;Ipilimumab
19 Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors Recruiting NCT03507244 Phase 1, Phase 2 Pemetrexed;Dexamethasone
20 Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors Recruiting NCT03082144 Phase 2 MTX;Ara-C
21 Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS Recruiting NCT03257124 Phase 2 AZD9291
22 Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis Recruiting NCT02422641 Phase 2 High-dose Methotrexate (8 gm/m2; HD-MTX)
23 Pembrolizumab in Patients With Leptomeningeal Disease Recruiting NCT03091478 Phase 2 Pembrolizumab
24 Pembrolizumab In Central Nervous System Metastases Recruiting NCT02886585 Phase 2 Pembrolizumab
25 Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors Recruiting NCT02684071 Phase 2 Intra thecal methotrexate;topotecan;cyclophosphamide
26 A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy Recruiting NCT03608020 Phase 1, Phase 2 BMX-001
27 Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis Active, not recruiting NCT01373710 Phase 1, Phase 2 Trastuzumab
28 Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer Active, not recruiting NCT01325207 Phase 1, Phase 2
29 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
30 Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer Active, not recruiting NCT01797159 Phase 2
31 A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain Active, not recruiting NCT02308020 Phase 2 Abemaciclib
32 Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD Not yet recruiting NCT03501979 Phase 2 Tucatinib;Trastuzumab;Capecitabine
33 DepoCyt for Active Lymphomatous or Leukemic Meningitis Terminated NCT00523939 Phase 2 cytarabine liposome injection
34 Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Terminated NCT00005812 Phase 2 temozolomide
35 A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer Terminated NCT00830245 Phase 2 Erlotinib
36 Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System Terminated NCT01596127 Phase 1, Phase 2 Intrathecal Rituximab
37 Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala Terminated NCT01857752 Phase 2 Temozolomide
38 Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer Terminated NCT02154529 Phase 1, Phase 2 Tesevatinib
39 Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors Unknown status NCT00003073 Phase 1 liposomal cytarabine
40 Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer Completed NCT03101579 Phase 1 Pemetrexed;Dexamethasone;Folic Acid;Vitamin B12
41 Phase 1 Intrathecal Topotecan for Neoplastic Meningitis Completed NCT00674674 Phase 1 Topotecan;Topotecan;Topotecan
42 Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. Completed NCT00854867 Phase 1 Whole Brain Radio Therapy (WBRT) with sequential Depocyte;Whole brain radiotherapy (WBRT) with concomitant Depocyte
43 Melphalan in Patients With Neoplastic Meningitis Completed NCT00002750 Phase 1 melphalan
44 High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations Completed NCT00372515 Phase 1 Gefitinib
45 LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases Completed NCT00003020 Phase 1
46 Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors Completed NCT00003462 Phase 1 busulfan
47 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer Completed NCT00006246 Phase 1 busulfan
48 Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors Completed NCT00031928 Phase 1 mafosfamide
49 Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain Completed NCT00025311 Phase 1 topotecan hydrochloride
50 Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer Completed NCT00003022 Phase 1

Search NIH Clinical Center for Lymphomatous Meningitis

Genetic Tests for Lymphomatous Meningitis

Anatomical Context for Lymphomatous Meningitis

MalaCards organs/tissues related to Lymphomatous Meningitis:

41
Lymph Node, Brain, Lung, Breast, Bone, T Cells, Spinal Cord

Publications for Lymphomatous Meningitis

Articles related to Lymphomatous Meningitis:

(show top 50) (show all 84)
# Title Authors Year
1
Sudden blindness and deafness disclosing meningeal carcinomatosis in non-small cell lung cancer. ( 30523521 )
2018
2
Successful Treatment with Osimertinib and Chemotherapy in a Non-Small Cell Lung Cancer Patient with EGFR Mutation and Meningeal Carcinomatosis. ( 30368410 )
2018
3
Diagnosis and Management of Leukemic and Lymphomatous Meningitis. ( 28178710 )
2017
4
Meningeal carcinomatosis and spinal cord infiltration caused by a locally invasive pulmonary adenocarcinoma in a cat. ( 29204290 )
2017
5
Extensive Involvement of Multiple Cranial and Spinal Nerves in Lymphomatous Meningitis. ( 28482940 )
2017
6
Efficacy of Intrathecal MTX/Ara-C Combined with Systemic Chemotherapy in a Gastric Cancer Patient with Meningeal Carcinomatosis. ( 26984076 )
2016
7
Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients. ( 26715407 )
2015
8
Meningeal carcinomatosis in a patient with Crohn's disease. ( 25338348 )
2014
9
Successful long-term control of lymphomatous meningitis with intraventricular rituximab. ( 24054402 )
2014
10
Meningeal carcinomatosis: a metastasis from gastroesophageal junction adenocarcinoma. ( 24454393 )
2013
11
Anaplastic ependymoma with holocordal and intracranial meningeal carcinomatosis and holospinal bone metastases. ( 23422903 )
2013
12
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa. ( 24043602 )
2013
13
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis. ( 23588955 )
2013
14
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution. ( 21229289 )
2012
15
Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report. ( 23249254 )
2012
16
Progressive multiple cranial nerve palsies as the presenting symptom of meningeal carcinomatosis from occult colon adenocarcinoma. ( 22466842 )
2012
17
Intrathecal chemotherapy in lymphomatous meningitis. ( 20696592 )
2011
18
Lymphomatous meningitis as a presentation of non-Hodgkin lymphoma. ( 21685872 )
2011
19
A case of primary uterine cervical neuroendocrine tumor with meningeal carcinomatosis confirmed by diagnostic imaging and autopsy. ( 21161314 )
2011
20
[A case of meningeal carcinomatosis due to gastric cancer treated with intrathecal chemotherapy]. ( 21971143 )
2011
21
Sudden bilateral sensorineural hearing loss as the presenting symptom of meningeal carcinomatosis of gastric cancer: report of a case. ( 20496139 )
2010
22
Meningeal carcinomatosis: an extremely rare involvement of urinary bladder carcinoma. ( 20572600 )
2010
23
Undiagnosed collecting duct carcinoma presenting as meningeal carcinomatosis and multiple bone metastases. ( 20686287 )
2010
24
Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma. ( 20108270 )
2010
25
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C. ( 18820836 )
2009
26
Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment. ( 19596957 )
2009
27
Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis. ( 19856060 )
2009
28
Lymphomatous meningitis: early diagnosis and treatment. ( 19193553 )
2009
29
Meningeal carcinomatosis and uterine carcinoma: three different clinical settings and review of the literature. ( 19258961 )
2009
30
Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments. ( 18201152 )
2008
31
Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis. ( 17324339 )
2007
32
Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study. ( 17915026 )
2007
33
Liposomal cytarabine: new drug. Lymphomatous meningitis: no better than standard cytarabine. ( 16548098 )
2006
34
Lymphomatous meningitis in primary central nervous system lymphoma. ( 17134122 )
2006
35
A case of meningeal carcinomatosis presenting with the primary symptoms of facial palsy and sensorineural deafness. ( 16936452 )
2006
36
The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas. ( 16531273 )
2006
37
Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report. ( 17042768 )
2006
38
Meningeal carcinomatosis preceded by a rapid increase in serum CA19-9 levels in a patient with breast cancer. ( 16136375 )
2005
39
Epstein Barr-virus (EBV) associated T-cell clonopathy mimicking lymphomatous meningitis. ( 15765199 )
2005
40
Intrathecal chemotherapy for patients with meningeal carcinomatosis. ( 15639526 )
2005
41
Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. ( 16215818 )
2005
42
Primary CNS lymphoma: is there a role for prophylaxis against lymphomatous meningitis? ( 15853551 )
2004
43
Meningeal carcinomatosis - an unusual cause of multiple cranial nerve palsies and sensory neuropathy. ( 15627681 )
2004
44
Meningeal carcinomatosis as the initial manifestation of a gallbladder adenocarcinoma associated with a Krukenberg tumor. ( 12894314 )
2003
45
Meningeal carcinomatosis: a rare cause of cauda equina syndrome. ( 16868375 )
2003
46
Generation of dendritic cells from the ventricular fluid in patients with meningeal carcinomatosis. ( 12864986 )
2003
47
Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder. ( 12814256 )
2003
48
Lymphomatous meningitis of the Burkitt type presenting with multiple cranial neuropathies. ( 11860991 )
2002
49
Meningeal carcinomatosis from an ovarian primary with complete response to adjuvant chemotherapy after cranial irradiation. ( 11706787 )
2001
50
Pathologic quiz case: progressive diffuse weakness after chemotherapy for large cell lymphoma in a middle-aged woman. Lymphomatous meningitis with neurolymphomatosis. ( 10747335 )
2000

Variations for Lymphomatous Meningitis

Expression for Lymphomatous Meningitis

Search GEO for disease gene expression data for Lymphomatous Meningitis.

Pathways for Lymphomatous Meningitis

Pathways related to Lymphomatous Meningitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.02 CEACAM5 IL2RB
2 10.14 FN1 IL2RB

GO Terms for Lymphomatous Meningitis

Sources for Lymphomatous Meningitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....